-
International Journal of Nephrology and Renovascular Disease
- About Dovepress
Open access peer-reviewed scientific and medical journals.
- Open Access
Dove Medical Press is now a member of the Open Access Initiative
- An Author's Guide
A guide to help authors get their paper published.
- Advocacy
Support Open Access and Dove Press
- Reprints
Promotional Article Monitoring - further details
- Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Review
(7320) Total Article Views
Authors: Antonio V Gaddi, Arrigo FG Cicero, Giovanni Gambaro
Published Date July 2010 Volume 2010:3 Pages 99 - 105
DOI: http://dx.doi.org/10.2147/IJNRD.S5943
Antonio V Gaddi1, Arrigo FG Cicero1, Giovanni Gambaro2
1Atherosclerosis and Metabolic disease Research Unit, Internal Medicine, Aging and Kidney diseases Dept., University of Bologna, Italy; 2Nephrology and Dialysis Unit, Gemelli University Hospital, Sacred Heart Catholic University, Rome, Italy
Abstract: A relatively large body of evidence supports the notion that glomerular capillary wall and mesangial alterations in diabetic nephropathy involve biochemical alterations of glycoproteins in these structures. Evidence in experimental animals rendered diabetic reveals that the administration of heparin and other anionic glycoproteins can effectively prevent the biochemical alterations that promote albuminuria. Moreover, angiotensin II inhibits heparan sulfate synthesis, while heparins modulate angiotensin II signaling in glomerular cells, inhibiting aldosterone synthesis and lowering proteinuria in diabetes patients. Sulodexide, a mixture of heparin and dermatan sulfate, appears to be a promising treatment for diabetic proteinuria partially resistant to renin–angiotensin system blocking agents. Sulodexide prevents heparan sulfate degradation, thus allowing reconstruction of heparan sulfate content and restoration of glomerular basement membrane ionic permselectivity. The antiproteinuric effect appears to be mainly related to the basal proteinuria and consequently to the duration of treatment in a relatively large number of small clinical trials. On the other hand, several sulodexide pharmacodynamic properties could improve the prognosis of chronic kidney disease patients, also independently from its antiproteinuric effect. However, sulodexide development as an antiproteinuric drug needs to be continued, in order to define which kind of patients could better respond to this treatment.
Keywords: glycosaminoglycans, sulodexide, albuminuria, proteinuria, diabetic nephropathy
Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter
Other articles by Dr Arrigo Cicero
Readers of this article also read:
- Call For Submissions
Submit Original Research Article, Review, Case Report, or Rapid Communication in International Journal of Nephrology and Renovascular Disease
- Functional evaluation of the urinary tract by duplex Doppler ultrasonography in patients with acute renal colic
- Potential renovascular hypertension, space missions, and the role of magnesium
- Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs
- The use of everolimus in renal-transplant patients